Director DMPK and Bioanalysis – Medivir AB - Avslutad
Medivir is an innovative pharmaceutical company with a focus on infectious diseases dedicated to provide patients with new and innovative products, to prevent and cure diseases and to enhance their quality of life. Medivir invent, develop and intends to successfully market pharmaceuticals that effectively and selectively inhibit protease and polymerase enzymes as drug targets. Medivir’s business focus is to be a profitable, medium-sized high-growth pharmaceutical company with its prime strength in infectious diseases within a five-year period.
The portfolio consists of ten projects, of which XerclearTM is in the market launch phase, six projects are in clinical or preclinical development stage and the remaining three are in earlier phases. The company has been quoted on NASDAQ OMX Stockholm since 1996.
The position – Director DMPK and Bioanalysis
The successful candidate will take on the position as Director of DMPK and Bioanalysis. The department consist of eight employees working in DMPK, in vivo and in vitro, and in Bioanalysis. The work, which is conducted in modern facilities with advanced analytical instrumentation, is research intensive with a working climate characterised by innovation, creativity and delivery.
The candidate will have a Ph.D. in a relevant discipline and with good theoretical and practical knowledge and understanding in all major areas of DMPK, e.g. in vitro and in vivo assays for metabolism and permeability, bioanalysis, scaling to man and PK and PK/PD calculations. The candidate will have a track record as specialist within one of the above areas and will have a minimum of 5 years of experience from the pharmaceutical industry with a very good understanding of the R&D processes. The candidate must also have strong ability to document work in written reports and to present orally for both internal and external audiences. Strong leadership abilities and demonstrated experience of teamwork is a key required for this position. The position reports to the CSO.
Medivir is cooperating with the recruitment agency Aktivia Science Work AB in this recruitment project so questions related to this position should be made to Mr. Knut Natt och Dag at +46 722 166 800 or Mr. Rolf Mayer at +46 708 87 60 05. Applications containing a CV and a short personal letter should be sent to email@example.com. We are working rapidly with this recruitment project and would like to receive your application as soon as possible.